Patents by Inventor Daniel Ortiz Velez

Daniel Ortiz Velez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11915795
    Abstract: Methods are provided for nucleic acid analysis via a platform which incorporates a digital sample partitioning platform such as a microfluidic chip or digital droplet platform and instrumentation to accomplish universal amplification, High Resolution Melting (HRM), and machine learning within reactions simultaneously.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: February 27, 2024
    Assignee: The Regents of the University of California
    Inventors: Stephanie I. Fraley, Sinead Charpentier, Daniel Ortiz Velez, Mridu Sinha, Benjamin Albert Yang
  • Publication number: 20230375527
    Abstract: Disclosed herein is a novel gene signature of metastatic cancer cells and a novel three-dimensional (3D) culture system for use in improved methods of predicting metastasis or prognosis in cancer. Accordingly, described herein are methods of determining a risk of metastasis, methods of predicting prognosis for cancer patients, methods of treating a cancer patient identified at high risk of metastasis, methods of treating a cancer patient identified as having poorer prognosis, methods for determining the migration capacity of a tumor, methods of screening a tumor for sensitivity to a drug, and kits for use in performing these methods.
    Type: Application
    Filed: February 15, 2023
    Publication date: November 23, 2023
    Inventors: Stephanie Fraley, Hannah Carter, Daniel Ortiz Velez, Brian Tsui
  • Publication number: 20210241857
    Abstract: Methods are provided for nucleic acid analysis via a platform which incorporates a digital sample partitioning platform such as a microfluidic chip or digital droplet platform and instrumentation to accomplish universal amplification, High Resolution Melting (HRM), and machine learning within reactions simultaneously.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 5, 2021
    Inventors: Stephanie I Fraley, Sinead Charpentier, Daniel Ortiz Velez, Mridu Sinha, Benjamin Albert Yang
  • Publication number: 20190293630
    Abstract: Disclosed herein is a novel gene signature of metastatic cancer cells and a novel three-dimensional (3D) culture system for use in improved methods of predicting metastasis or prognosis in cancer. Accordingly, described herein are methods of determining a risk of metastasis, methods of predicting prognosis for cancer patients, methods of treating a cancer patient identified at high risk of metastasis, methods of treating a cancer patient identified as having poorer prognosis, methods for determining the migration capacity of a tumor, methods of screening a tumor for sensitivity to a drug, and kits for use in performing these methods.
    Type: Application
    Filed: December 1, 2017
    Publication date: September 26, 2019
    Inventors: Stephanie Fraley, Hannah Carter, Daniel Ortiz Velez, Brian Tsui